The reuters report didn't say that but the genetic test will probably look for patients who are positive for the Anaplastic Lymphoma Kinase (ALK) fusion gene (variants of EML4-ALK fusion gene).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.